incretin mimetic agents glp 1 receptor agonists Introduction to Diabetes Type and Type 2 GLP-1 actions and target organs.

This reduces the risk of hypoglycaemia compared to some other diabetes treatments, although the risk increases when used with insulin or sulfonylureas

It inhibits the pigment responsible for dark spots and uneven skin tone, leading to a more even complexion and reduced hyperpigmentation

Ce nouveau rle pourrait expliquer la lipodystrophie des patients qui nont pas de HSL et ouvre des pistes pour mieux comprendre les maladies mtaboliques telles que lobsit et ses complications

Long-term and liver-selected ginsenoside CK nanoparticles retard nafld progression by restoring lipid homeostasis

Tesamorelin (TH9507) is a synthesized version of GHRH, retaining its same 44 amino acid composition but enhanced via a trans-3-hexenoic acid attachment at the N-terminus

Mealo Liquid L-Carnitine+Energy comes in a refreshing Litchee flavor